MedTrace Logo

Opinions of Company Representatives About Neuromodulation

NCT05013827 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 39

Last updated 2022-01-14

No results posted yet for this study

Summary

The goal of this online survey is to gain further insight in the goals, expectations and definition of success for neuromodulation for pain, according to neuromodulation company representatives.

Conditions

  • Neuromodulation
  • Pain
  • Survey

Interventions

BEHAVIORAL

Filling in an online survey

Company representatives are questioned about three aspects: 1) goals in treating patients with neuromodulation for pain, 2) factors that respondents expect to change according to neuromodulation for pain and 3) their definition of success of neuromodulation for pain.

Sponsors & Collaborators

  • Moens Maarten

    lead OTHER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2021-09-02
Primary Completion
2021-09-09
Completion
2021-09-09

Countries

  • Belgium

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05013827 on ClinicalTrials.gov